73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

byThe Spanish National Cancer Research CentreCNIO researchers Bruna Calsina (left) and Mercedes Robledo. Credit: Laura M. Lombardía, CNIOPheochromocytoma is a rare tumor, with an incidence of th

Study of rare cancer identifies patients at highest risk of metastasis and those who would respond to immunotherapy

byThe Spanish National Cancer Research CentreCNIO researchers Bruna Calsina (left) and Mercedes Robledo. Credit: Laura M. Lombardía, CNIOPheochromocytoma is a rare tumor, with an incidence of th
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainPeople with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton

IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainPeople with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton
For some small kidney cancers, freezing is more effective than heat treatment

For some small kidney cancers, freezing is more effective than heat treatment

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer

For some small kidney cancers, freezing is more effective than heat treatment

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer
Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute
From vaccines to AI: New weapons in the fight against cancer

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl
Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patientsby Julia Evangelou Strait,Washington University School of MedicineShown are multiple myeloma cells from a

Investigational drug may improve stem cell transplantation for multiple myeloma patients

Investigational drug may improve stem cell transplantation for multiple myeloma patientsby Julia Evangelou Strait,Washington University School of MedicineShown are multiple myeloma cells from a
International study designed to identify melanoma patients with high-risk disease

International study designed to identify melanoma patients with high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe use of additional adjuvant therapy beyond initial treatment has greatly im

International study designed to identify melanoma patients with high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteMelanoma. Credit: Wikimedia Commons/National Cancer InstituteThe use of additional adjuvant therapy beyond initial treatment has greatly im
Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m
Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar
Scientists reveal a potential new approach to treating liver cancer

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library